New York Life Investment Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,847
Closed -$229K 1457
2023
Q4
$229K Sell
4,847
-131
-3% -$5.44K ﹤0.01% 1278
2023
Q3
$237K Sell
4,978
-784
-14% -$42.8K ﹤0.01% 1246
2023
Q2
$335K Sell
5,762
-997
-15% -$59.8K ﹤0.01% 1197
2023
Q1
$483K Sell
6,759
-2,095
-24% -$166K 0.01% 836
2022
Q4
$624K Buy
8,854
+950
+12% +$67K 0.01% 745
2022
Q3
$479K Buy
7,904
+625
+9% +$41.9K 0.01% 779
2022
Q2
$460K Buy
+7,279
New +$474K 0.01% 770

Other funds holding NGVT

New York Life Investment Management's NGVT Position: Q1 2024 in Review

New York Life Investment Management sold out of Ingevity (NGVT) in Q1 2024, closing a stake of 4,847 shares — an estimated $229K sold.

New York Life Investment Management first reported a position in NGVT in Q2 2022 and held it in 7 quarters. The position peaked at $624K in Q4 2022. 259 funds tracked by Wall St. Rank hold NGVT as of Q1 2024.

  • New York Life Investment Management reported no remaining Ingevity position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 4,847 Ingevity shares in Q1 2024, an estimated $229K.
  • New York Life Investment Management first reported a position in Ingevity in Q2 2022 and held it in 7 quarters.
  • New York Life Investment Management's Ingevity position peaked at $624K in Q4 2022.
  • 259 funds tracked by Wall St. Rank held Ingevity as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.